Truvestments Capital LLC Exelixis, Inc. Transaction History

Truvestments Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$17.44 - $23.16 $2,040 - $2,709	117 New	117 $2,000
Q4 2019 Jan 29, 2020	SELL	$15.15 - $18.89 $3,954 - $4,930	-261 Closed	0 $0
Q3 2019 Oct 10, 2019	BUY	$17.68 - $22.65 $1,838 - $2,355	104 Added 66.24%	261 $5,000
Q2 2019 Jul 15, 2019	BUY	$18.93 - $24.75 $2,972 - $3,885	157 New	157 $3,000

507

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Truvestments Capital LLC with notifications on news.